200 related articles for article (PubMed ID: 20370848)
41. Incidental detection of renal transplantation urinary leakage on FDG-PET/CT imaging for evaluation of lung metastases.
Banzo I; Martinez-Rodriguez I; Quirce R; Jimenez-Bonilla J; Sainz-Esteban A; Barragán J; Portilla-Quattocciochi H; Medina-Quiroz P; Carril JM
Clin Nucl Med; 2009 Dec; 34(12):924-6. PubMed ID: 20139837
[No Abstract] [Full Text] [Related]
42. PET in testicular cancer.
Becherer A
Methods Mol Biol; 2011; 727():225-41. PubMed ID: 21331937
[TBL] [Abstract][Full Text] [Related]
43. Imaging of pelvic malignancies with in-line FDG PET-CT: case examples and common pitfalls of FDG PET.
Subhas N; Patel PV; Pannu HK; Jacene HA; Fishman EK; Wahl RL
Radiographics; 2005; 25(4):1031-43. PubMed ID: 16009822
[TBL] [Abstract][Full Text] [Related]
44. Penile metastases from bladder and prostate cancer detected by PET/CT: a report of 3 cases and a review of literature.
Spinapolice EG; Fuccio C; Rubino B; Palumbo R; Mensi M; Scopesi L; Trifirò G; Ivaldi GB
Clin Genitourin Cancer; 2014 Aug; 12(4):e155-9. PubMed ID: 24787969
[No Abstract] [Full Text] [Related]
45. Detection, staging and surveillance in renal cell carcinoma.
Francis IR
Cancer Imaging; 2006 Nov; 6(1):168-74. PubMed ID: 17098649
[TBL] [Abstract][Full Text] [Related]
46. Role of FDG PET/CT in imaging of renal lesions.
Kochhar R; Brown RK; Wong CO; Dunnick NR; Frey KA; Manoharan P
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):347-57. PubMed ID: 20718915
[TBL] [Abstract][Full Text] [Related]
47. FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate.
Liu Y
World J Surg Oncol; 2008 Jun; 6():64. PubMed ID: 18565231
[TBL] [Abstract][Full Text] [Related]
48. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Aurangabadkar H; Ali Z
Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
[TBL] [Abstract][Full Text] [Related]
49. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
Sugawara Y; Zasadny KR; Grossman HB; Francis IR; Clarke MF; Wahl RL
Radiology; 1999 Apr; 211(1):249-56. PubMed ID: 10189480
[TBL] [Abstract][Full Text] [Related]
50. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in urological cancers].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S80-7. PubMed ID: 12739339
[No Abstract] [Full Text] [Related]
51. Metabolic imaging with FDG: a primer.
Delbeke D; Martin WH
Cancer J; 2004; 10(4):201-13. PubMed ID: 15383201
[TBL] [Abstract][Full Text] [Related]
52. Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer.
Goh V; Cook G
BJU Int; 2013 Oct; 112(6):709. PubMed ID: 24028759
[No Abstract] [Full Text] [Related]
53. Positron emission tomography in urologic oncology.
Shvarts O; Han KR; Seltzer M; Pantuck AJ; Belldegrun AS
Cancer Control; 2002; 9(4):335-42. PubMed ID: 12228759
[TBL] [Abstract][Full Text] [Related]
54. PET/CT in prostate cancer: an unmet clinical need.
Mintz A
Oncology (Williston Park); 2014 Dec; 28(12):1065-6. PubMed ID: 25738198
[No Abstract] [Full Text] [Related]
55. [Tumor markers in urological malignancies].
Kuriyama M
Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
[TBL] [Abstract][Full Text] [Related]
56. CT with anatomic delineation identifying renal cell carcinoma with normal metabolic activity on F-18 FDG PET imaging.
Cherng SC; Chang CY; Fan YM; Chen CY; Chiu CS; Cheng CY
Clin Nucl Med; 2006 Aug; 31(8):490-1. PubMed ID: 16855441
[No Abstract] [Full Text] [Related]
57. Diagnosis and monitoring of urological tumors using positron emission tomography.
Hofer C; Kübler H; Hartung R; Breul J; Avril N
Eur Urol; 2001 Nov; 40(5):481-7. PubMed ID: 11752853
[TBL] [Abstract][Full Text] [Related]
58. Genitourinary involvement of lymphomas on FDG-PET.
Naik N; Lin M; Lin P
Br J Radiol; 2018 Jun; 91(1086):20170273. PubMed ID: 29322833
[TBL] [Abstract][Full Text] [Related]
59. Positron-emission tomography imaging in urological oncology: Current aspects and developments.
Rauscher I; Eiber M; Weber WA; Gschwend JE; Horn T; Maurer T
Int J Urol; 2018 Nov; 25(11):912-921. PubMed ID: 30103285
[TBL] [Abstract][Full Text] [Related]
60. Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature.
Bilen MA; Hariri H; Leon C; Guo CC; Kuban DA; Pisters LL; Tu SM
Clin Genitourin Cancer; 2014 Aug; 12(4):e147-50. PubMed ID: 24674785
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
